Search Results - "Kuwahara‐Ota, Saeko"
-
1
Lenalidomide and pomalidomide potently interfere with induction of myeloid‐derived suppressor cells in multiple myeloma
Published in British journal of haematology (01-12-2020)“…Summary An increase in immunosuppressive myeloid‐derived suppressor cells (MDSCs) is associated with disease progression and treatment resistance in multiple…”
Get full text
Journal Article -
2
Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering miR ‐106a‐5p and miR ‐146a‐5p in multiple myeloma
Published in British journal of haematology (01-11-2023)“…The shift of the tumour immune microenvironment to a suppressive state promotes not only the development and progression of the disease in multiple myeloma…”
Get full text
Journal Article -
3
Toward further simplification of elotuzumab therapy by subcutaneous administration
Published in International journal of hematology (01-09-2020)Get full text
Journal Article -
4
EWSR1 overexpression is a pro-oncogenic event in multiple myeloma
Published in International journal of hematology (01-03-2021)“…Multiple myeloma (MM) is cytogenetically, genetically and molecularly heterogenous even among subclones in one patient, therefore, it is essential to identify…”
Get full text
Journal Article -
5
Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma
Published in Cancer medicine (Malden, MA) (01-07-2020)“…RSK2 is a serine/threonine kinase downstream signaling mediator in the RAS/ERK signaling pathway and may be a therapeutic target in mantle cell lymphoma (MCL),…”
Get full text
Journal Article -
6
A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma
Published in International journal of hematology (01-05-2019)“…Chromosomal microdeletions frequently cause loss of prognostically relevant tumor suppressor genes in hematologic malignancies; however, detection of minute…”
Get full text
Journal Article -
7
Chromosomal abnormality variation detected by G‐banding is associated with prognosis of diffuse large B‐cell lymphoma treated by R‐CHOP‐based therapy
Published in Cancer medicine (Malden, MA) (01-03-2018)“…Diffuse large B‐cell lymphoma (DLBCL), which is the most prevalent disease subtype of non‐Hodgkin lymphoma, is highly heterogeneous in terms of cytogenetic and…”
Get full text
Journal Article -
8
Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System
Published in Oncology letters (01-02-2024)“…Azacitidine (AZA) has been one of the standard treatments for transplantation-ineligible patients with myelodysplastic syndrome (MDS); however, hematological…”
Get full text
Journal Article -
9
Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia
Published in Haematologica (Roma) (01-08-2019)Get full text
Journal Article -
10
Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma
Published in Cancers (06-08-2020)“…Chromosome instability (CIN), the hallmarks of cancer, reflects ongoing chromosomal changes caused by chromosome segregation errors and results in whole…”
Get full text
Journal Article -
11
-
12
Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities
Published in Experimental hematology (01-04-2020)“…•Mantle cell lymphoma and multiple myeloma with 11q13 abnormalities express Cyclin D1 transcript variants with longer 5′-UTRs.•Cyclin D1 transcript variants…”
Get full text
Journal Article -
13
Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system
Published in International journal of hematology (01-09-2023)“…The prognostic impact of patient-related factors, including age, nutritional parameters, and inflammation status, in higher-risk myelodysplastic syndromes…”
Get full text
Journal Article -
14
BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach
Published in Cancer genomics & proteomics (01-01-2020)“…Background: Since bromodomain-containing protein 4 (BRD4) facilitates the transcription of genes important for neoplastic cells in a cancer-type specific…”
Get full text
Journal Article -
15
Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma
Published in Leukemia & lymphoma (06-12-2019)“…Delayed platelet engraftment (DPE) is occasionally observed despite prompt neutrophil engraftment after autologous peripheral blood stem cell transplantation…”
Get full text
Journal Article -
16
Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib
Published in Infection and drug resistance (01-01-2020)“…Ruxolitinib is a selective JAK1/2 inhibitor that is widely used for the treatment of myeloproliferative neoplasms (MPNs), including myelofibrosis and…”
Get full text
Journal Article -
17
Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma
Published in Experimental hematology (01-03-2018)“…•3-Phosphoinositide-dependent protein kinase 1 (PDPK1) is found to be constitutively activated in various types of patient-derived B-cell non-Hodgkin lymphoma…”
Get full text
Journal Article -
18
Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab
Published in Infection and drug resistance (01-01-2018)“…Primary infection with human herpesvirus-6 (HHV-6) commonly occurs at an early age in children, most often at 3 years of age, and is associated with childhood…”
Get full text
Journal Article -
19
Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib
Published in Infection and drug resistance (01-01-2020)Get full text
Report -
20